Article

In vitro efficacy of Fasting Mimicking Conditions combined with targeting of starvation escape pathways against prostate cancer cells

2025-09-01

Abstract excerpt

Prostate cancer (PCa) remains a leading cause of cancer-related death among men, particularly due to the development of treatment-resistant disease such as castration-resistant prostate cancer (CRPC) 1 . Emerging evidence suggests that metabolic interventions like the fasting-mimicking diet (FMD), which promotes differential fasting responses in normal and cancer cells, can enhance the efficacy of conventional th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ce0fd5d7-c098-590a-a128-2f9508caba19
DOI: 10.1101/2025.08.27.672470

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

In vitro efficacy of Fasting Mimicking Conditions combined with targeting of starvation escape pathways against prostate cancer cellsDOI 10.1101/2025.08.27.672470Read

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Semantic proximity Read

New insights into lipid metabolism and prostate cancer (Review)Semantic proximity Read

PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal.Semantic proximity Read

Subtype and Site Specific–Induced Metabolic Vulnerabilities in Prostate CancerSemantic proximity Read

Screening in serum-derived medium reveals differential response to compounds targeting metabolismSemantic proximity Read

Human bone marrow adipocytes drive prostate cancer bone metastasis progression via lipid-mediated induction of Angiopoietin-like 4Semantic proximity Read

GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasisSemantic proximity Read

Polyunsaturated Fatty Acids from Thamnidium elegans and Mortierella alpina Suppress Prostate Cancer Cell Proliferation and MigrationSemantic proximity Read

Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelSemantic proximity Read

Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancerSemantic proximity Read

Androgens Promote Prostate Cancer Cell Growth through Induction of AutophagySemantic proximity Read

Integrated proteomics and metabolomics analysis reveals new insight into the synergistic antitumor effect of valproic acid plus simvastatin in prostate cancer xenograft model associated with downmodulation of YAP/TAZ signalingSemantic proximity Read